Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSGeneric

GONAL-F

FOLLITROPIN ALFA/BETA

Standard Dose
37.5 IU/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview GONAL-F is listed in Drugs@FDA under application 021765 (BLA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FOLLITROPIN ALFA/BETA Form and strength INJECTABLE;SUBCUTANEOUS - 37.5 IU/VIAL Sponsor EMD SERONO Submission history Latest submission status date: 2023-11-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview GONAL-F is listed in Drugs@FDA under application 021765 (BLA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FOLLITROPIN ALFA/BETA Form and strength INJECTABLE;SUBCUTANEOUS - 37.5 IU/VIAL Sponsor EMD SERONO Submission history Latest submission status date: 2023-11-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
GONAL-F (FOLLITROPIN ALFA/BETA) | Drug Monograph | MedicHelpline